Sumber Sinergi Makmur Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sumber Sinergi Makmur Tbk. trades at Rp72 (market cap 386.19B, 248.07M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Sumber Sinergi Makmur Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sumber Sinergi Makmur Tbk. is more actively traded (248.07M versus 187.4K). Which is the better fit depends on your goals.
| IOTF | OBAT | |
|---|---|---|
Market Cap | 386.19B | 164.65B |
Volume | 248.07M | 187.4K |
Lot | 2.48M | 1.87K |
Turnover | 18.39B | 44.35M |
Average Price | 74.12 | 236.67 |
Value | 18.39B | 44.35M |
Indicative Equilibrium Price | 72 | 242 |
Indicative Equilibrium Volume | 35.51K | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sumber Sinergi Makmur Tbk (the Company) was established based on Deed Number 88 dated May 19, 2015 of H. Zainuddin, S.H., a notary domiciled in Jakarta. The company started its commercial activities in 2015. The controlling party of the Company and the party who is the ultimate beneficial owner of the Company is Alamsyah.
Read more on IOTF →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →